Javier Iván Lasso Apráez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Javier Iván Lasso Apráez has a total of 73 co-authors. Here are the top co-authors by number of shared publications:
- Carlos Andrés Celis Preciado
Faculté de Médecine et des Sciences de la Santé Université de Sherbrooke Sherbrooke Québec Canada
2 shared publications - Claudio Villaquirán Torres
Hospital Universitario San Ignacio
2 shared publications - Dolfus Santiago Romero Rojas
Pulmology Department, Hospital Universitario San Ignacio, Bogotá 110231, Colombia
2 shared publications Javier Ricardo Garzón Herazo
Pontificia Universidad Javeriana
2 shared publications- Juan David Botero Bahamon
Department of Internal Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia
2 shared publications - Leonel Alberto Dajaro-Castro
Hospital Universitario San Ignacio
2 shared publications
Latest Publications
- Open Access
- 15 July 2026
- Published by Asociacion Colombiana de Neumologia y Cirugia de Torax in Revista Colombiana de Neumología
- Vol. 38 (1Supp1) , 1-85
Consenso Colombiano de Uso de Ventilación Mecánica no invasiva en pacientes con Enfermedades neuromusculares
Introducción: la ventilación no invasiva (VNI) ha demostrado ser un método eficaz, simple y de bajo costo para el tratamiento de la falla respiratoria hipercápnica crónica. Sin embargo, su evidencia clínica ha sido descrita principalmente en pacientes con enfermedad pulmonar obstructiva crónica (EPOC), hipoventilación, obesidad y edema pulmonar cardiogénico, con limitaciones importantes reportadas en las publicaciones de pacientes con enfermedad neuromuscular (ENM). Aunque existe la necesidad de realizar grandes estudios aleatorizados en este grupo de pacientes, la literatura y la experiencia clínica actual soportan de manera inequívoca el beneficio de la VNI en mejorar la calidad de vida, disminuir el riesgo de infecciones respiratorias e impactar la mortalidad en algunos grupos de pacientes. El objetivo de este consenso es realizar recomendaciones de expertos, basadas en la evidencia científica disponible y la experiencia adquirida en los pacientes con ENM. Metodología: se realizó una búsqueda estructurada basada en preguntas PICOT en diferentes bases de datos, incluyendo literatura publicada entre enero de 1992 y febrero de 2025. La selección de estudios fue realizada por revisores independientes y las recomendaciones se elaboraron con base en la estrategia GRADE. El acuerdo entre expertos se definió mediante metodología Delphi, considerando consenso con más del 75 % de los votos y recomendación muy fuerte con más del 90 %. Resultados: a partir de la evidencia identificada y del consenso de expertos, se formularon 57 recomendaciones para el uso de VNI en pacientes con falla ventilatoria crónica secundaria a ENM. Conclusiones: este consenso proporciona recomendaciones basadas en evidencia y en la experiencia de expertos para el uso de VNI en pacientes con ENM. A pesar de la limitada disponibilidad de estudios aleatorizados de gran tamaño, la evidencia actual apoya su beneficio en pacientes seleccionados y respalda su incorporación en la práctica clínica.
- 15 July 2026
- Published by Asociacion Colombiana de Neumologia y Cirugia de Torax in Revista Colombiana de Neumología
- Vol. 38 (1Supp1) , 1-85
Open AccessConsenso Colombiano de Uso de Ventilación Mecánica no invasiva en pacientes con Enfermedades neuromusculares
Introducción: la ventilación no invasiva (VNI) ha demostrado ser un método eficaz, simple y de bajo costo para el tratamiento de la falla respiratoria hipercápnica crónica. Sin embargo, su evidencia clínica ha sido descrita principalmente en pacientes con enfermedad pulmonar obstructiva crónica (EPOC), hipoventilación, obesidad y edema pulmonar cardiogénico, con limitaciones importantes reportadas en las publicaciones de pacientes con enfermedad neuromuscular (ENM). Aunque existe la necesidad de realizar grandes estudios aleatorizados en este grupo de pacientes, la literatura y la experiencia clínica actual soportan de manera inequívoca el beneficio de la VNI en mejorar la calidad de vida, disminuir el riesgo de infecciones respiratorias e impactar la mortalidad en algunos grupos de pacientes. El objetivo de este consenso es realizar recomendaciones de expertos, basadas en la evidencia científica disponible y la experiencia adquirida en los pacientes con ENM. Metodología: se realizó una búsqueda estructurada basada en preguntas PICOT en diferentes bases de datos, incluyendo literatura publicada entre enero de 1992 y febrero de 2025. La selección de estudios fue realizada por revisores independientes y las recomendaciones se elaboraron con base en la estrategia GRADE. El acuerdo entre expertos se definió mediante metodología Delphi, considerando consenso con más del 75 % de los votos y recomendación muy fuerte con más del 90 %. Resultados: a partir de la evidencia identificada y del consenso de expertos, se formularon 57 recomendaciones para el uso de VNI en pacientes con falla ventilatoria crónica secundaria a ENM. Conclusiones: este consenso proporciona recomendaciones basadas en evidencia y en la experiencia de expertos para el uso de VNI en pacientes con ENM. A pesar de la limitada disponibilidad de estudios aleatorizados de gran tamaño, la evidencia actual apoya su beneficio en pacientes seleccionados y respalda su incorporación en la práctica clínica.
- Open Access
- 9 December 2025
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 10 (12) , 346
Hidden in Plain Sight: Peritoneal Tuberculosis Mimicking Ovarian Neoplasm—A Case Report
Tuberculosis remains the deadliest infectious disease worldwide. Among extrapulmonary forms, peritoneal tuberculosis stands out as a rare and challenging diagnosis, often mistaken for intra-abdominal neoplasms or peritoneal carcinomatosis. The clinical, paraclinical, and imaging findings are similar and sometimes indistinguishable between the two entities, making the diagnosis a challenge for the treating physician. Here, we present the case of a young woman with chronic constitutional symptoms who presented to the emergency department with abdominal pain and ascites. An initial differential diagnosis of peritoneal carcinomatosis was considered based on findings in the peritoneal fluid and abdominal CT scan, leading to diagnostic laparoscopy. Histopathological examination of the samples revealed non-caseating granulomas involving the peritoneum, with no findings suggestive of malignancy. Subsequently, molecular testing for Mycobacterium tuberculosis was positive in the biopsies and peritoneal fluid, establishing the diagnosis of peritoneal tuberculosis. This case highlights the importance of awareness of peritoneal tuberculosis as a differential diagnosis of ascites and its significant potential to mimic other pathologies.
- 9 December 2025
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 10 (12) , 346
Open AccessHidden in Plain Sight: Peritoneal Tuberculosis Mimicking Ovarian Neoplasm—A Case Report
Tuberculosis remains the deadliest infectious disease worldwide. Among extrapulmonary forms, peritoneal tuberculosis stands out as a rare and challenging diagnosis, often mistaken for intra-abdominal neoplasms or peritoneal carcinomatosis. The clinical, paraclinical, and imaging findings are similar and sometimes indistinguishable between the two entities, making the diagnosis a challenge for the treating physician. Here, we present the case of a young woman with chronic constitutional symptoms who presented to the emergency department with abdominal pain and ascites. An initial differential diagnosis of peritoneal carcinomatosis was considered based on findings in the peritoneal fluid and abdominal CT scan, leading to diagnostic laparoscopy. Histopathological examination of the samples revealed non-caseating granulomas involving the peritoneum, with no findings suggestive of malignancy. Subsequently, molecular testing for Mycobacterium tuberculosis was positive in the biopsies and peritoneal fluid, establishing the diagnosis of peritoneal tuberculosis. This case highlights the importance of awareness of peritoneal tuberculosis as a differential diagnosis of ascites and its significant potential to mimic other pathologies.
- Open Access
- 24 April 2025
- Published by SAGE Publications in Therapeutic Advances in Infectious Disease
- Vol. 12
Factors associated with extrapulmonary tuberculosis in comparison to pulmonary tuberculosis in patients with and without HIV in Bogotá, Colombia: an observational study
Background: Extrapulmonary tuberculosis (EPTB) poses a public health challenge, particularly among individuals with human immunodeficiency virus (HIV). However, many EPTB cases arise in those without HIV, leaving the underlying factors unclear. Objectives: This study aims to characterize patients with pulmonary tuberculosis (PTB) and EPTB, exploring the differences in associated factors for each type in patients with and without HIV. Design: An analytical observational study was conducted on a cohort of tuberculosis (TB) patients diagnosed between 2014 and 2021 in a referral hospital in Bogotá, Colombia. Methods: Patients were categorized into PTB or EPTB based on the site of infection. Data on demographic and clinical variables were collected, comparing the two groups. A multivariate logistic regression model was created to identify factors associated with EPTB compared to PTB. Results: The study encompassed 533 patients: 310 with PTB and 223 with EPTB, of which only 65 (14.7%) were HIV positive. PTB patients exhibited higher rates of active smoking, smoking cessation, diabetes mellitus (DM), and other pulmonary diseases. The logistic regression identified HIV infection as the only factor associated with EPTB (OR 2.36 (1.54–3.61), p < 0.001). Conversely, quitting smoking (OR 0.58 (0.35–0.96) p = 0.038), DM (OR 0.41 (0.21–0.82) p = 0.011), chronic obstructive pulmonary disease (COPD) (OR 0.18 (0.08–0.4) p < 0.001), other pulmonary diseases (OR 0.21 (0.61–0.77) p = 0.019), or those using immunosuppressants (OR 0.44 (0.20–0.96) p = 0.04) exhibited a negative association with EPTB compared to PTB. Specific models for pleural and lymph node TB revealed distinct associations, with HIV strongly linked to lymph node TB (OR 3.38, 95% CI 1.57–7.26, p = 0.002). Conclusion: EPTB is primarily associated with HIV infection, while smoking, DM, COPD, other pulmonary diseases, and immunosuppressant use are associated with PTB. Variability in associated factors for specific EPTB forms underlines the need for tailored research into the predisposing factors for EPTB, particularly in HIV-negative patients.
- 24 April 2025
- Published by SAGE Publications in Therapeutic Advances in Infectious Disease
- Vol. 12
Open AccessFactors associated with extrapulmonary tuberculosis in comparison to pulmonary tuberculosis in patients with and without HIV in Bogotá, Colombia: an observational study
Background: Extrapulmonary tuberculosis (EPTB) poses a public health challenge, particularly among individuals with human immunodeficiency virus (HIV). However, many EPTB cases arise in those without HIV, leaving the underlying factors unclear. Objectives: This study aims to characterize patients with pulmonary tuberculosis (PTB) and EPTB, exploring the differences in associated factors for each type in patients with and without HIV. Design: An analytical observational study was conducted on a cohort of tuberculosis (TB) patients diagnosed between 2014 and 2021 in a referral hospital in Bogotá, Colombia. Methods: Patients were categorized into PTB or EPTB based on the site of infection. Data on demographic and clinical variables were collected, comparing the two groups. A multivariate logistic regression model was created to identify factors associated with EPTB compared to PTB. Results: The study encompassed 533 patients: 310 with PTB and 223 with EPTB, of which only 65 (14.7%) were HIV positive. PTB patients exhibited higher rates of active smoking, smoking cessation, diabetes mellitus (DM), and other pulmonary diseases. The logistic regression identified HIV infection as the only factor associated with EPTB (OR 2.36 (1.54–3.61), p < 0.001). Conversely, quitting smoking (OR 0.58 (0.35–0.96) p = 0.038), DM (OR 0.41 (0.21–0.82) p = 0.011), chronic obstructive pulmonary disease (COPD) (OR 0.18 (0.08–0.4) p < 0.001), other pulmonary diseases (OR 0.21 (0.61–0.77) p = 0.019), or those using immunosuppressants (OR 0.44 (0.20–0.96) p = 0.04) exhibited a negative association with EPTB compared to PTB. Specific models for pleural and lymph node TB revealed distinct associations, with HIV strongly linked to lymph node TB (OR 3.38, 95% CI 1.57–7.26, p = 0.002). Conclusion: EPTB is primarily associated with HIV infection, while smoking, DM, COPD, other pulmonary diseases, and immunosuppressant use are associated with PTB. Variability in associated factors for specific EPTB forms underlines the need for tailored research into the predisposing factors for EPTB, particularly in HIV-negative patients.
- Open Access
- 23 March 2025
- Published by Asociacion Latinoamericana de Torax in Respirar
- Vol. 17 (1) , 82-86
Fibrofoliculomas y enfermedad pulmonar quística: reporte de un caso
Birt-Hogg-Dubé syndrome (BHD) is a rare, autosomal dominant genetic disorder characterized by the development of skin lesions, lung cysts, spontaneous pneumothorax and kidney tumors. It results from the mutation in the folliculin gene (FLCN) located on the short arm of chromosome 17 (17p11.2). We present the case of a 63-year-old patient with a 30-year history of fibrofolliculomas and trichofolliculomas on the face and neck, accompanied by lung and kidney cysts. The diagnosis was confirmed by genetic testing, finding a mutation in the FLCN gene. Because it is a rare disease, knowing its clinical manifestations helps to diagnose it and perform adequate follow-up, which is important due to the risk of spontaneous pneumothorax and malignant kidney tumors.
- 23 March 2025
- Published by Asociacion Latinoamericana de Torax in Respirar
- Vol. 17 (1) , 82-86
Open AccessFibrofoliculomas y enfermedad pulmonar quística: reporte de un caso
Birt-Hogg-Dubé syndrome (BHD) is a rare, autosomal dominant genetic disorder characterized by the development of skin lesions, lung cysts, spontaneous pneumothorax and kidney tumors. It results from the mutation in the folliculin gene (FLCN) located on the short arm of chromosome 17 (17p11.2). We present the case of a 63-year-old patient with a 30-year history of fibrofolliculomas and trichofolliculomas on the face and neck, accompanied by lung and kidney cysts. The diagnosis was confirmed by genetic testing, finding a mutation in the FLCN gene. Because it is a rare disease, knowing its clinical manifestations helps to diagnose it and perform adequate follow-up, which is important due to the risk of spontaneous pneumothorax and malignant kidney tumors.
- Open Access
- 20 January 2025
- Published by Asociacion Colombiana de Neumologia y Cirugia de Torax in Revista Colombiana de Neumología
- Vol. 37 (1) , 63-68
Tuberculosis miliar con diseminación hematógena posterior a instilaciones de BCG intravesical: reporte de un caso
Miliary tuberculosis after intravesical immunotherapy with bacillus Calmette-Guerin (BCG) is rare. A few systemic complications associated with intravesical BCG instillations have been reported in the literature. In this case report, we present a patient with low-grade urothelial bladder cancer who presented clinical manifestations compatible with tuberculosis 4 hours after the last instillation of BCG as immunotherapy treatment for his bladder cancer. Consequently, a systematic approach was performed, finding micronodular infiltrates of random distribution in thoracic images suggestive of a Miliary pattern. The patient started anti-tuberculous treatment at the decision of an interdisciplinary board. Among the tests carried out, it was found that the endoscopic flexible fiberoptic bronchoscopy did not present alterations, the stains for AFB (acid-fast bacilli) in bronchoalveolar lavage were negative, as was the Gnexpert for Tuberculosis and culture. However, due to the symptoms and relevant risk factors, it was decided to perform wedge resection by thoracoscopy of the middle lobe, revealing a necrotizing granulomatous process whose histological appearance favored infectious etiology. The patient was diagnosed with miliary tuberculosis because of the symptoms presented, compatible radiology, biopsy findings, and clinical improvement, considering the antituberculosis treatment established. This article describes a case of miliary tuberculosis hematogenous spread in a patient who had previously received intravesical BCG instillations for the treatment of urothelial bladder cancer. Prompt treatment saves lives by avoiding a fatal outcome in these patients.
- 20 January 2025
- Published by Asociacion Colombiana de Neumologia y Cirugia de Torax in Revista Colombiana de Neumología
- Vol. 37 (1) , 63-68
Open AccessTuberculosis miliar con diseminación hematógena posterior a instilaciones de BCG intravesical: reporte de un caso
Miliary tuberculosis after intravesical immunotherapy with bacillus Calmette-Guerin (BCG) is rare. A few systemic complications associated with intravesical BCG instillations have been reported in the literature. In this case report, we present a patient with low-grade urothelial bladder cancer who presented clinical manifestations compatible with tuberculosis 4 hours after the last instillation of BCG as immunotherapy treatment for his bladder cancer. Consequently, a systematic approach was performed, finding micronodular infiltrates of random distribution in thoracic images suggestive of a Miliary pattern. The patient started anti-tuberculous treatment at the decision of an interdisciplinary board. Among the tests carried out, it was found that the endoscopic flexible fiberoptic bronchoscopy did not present alterations, the stains for AFB (acid-fast bacilli) in bronchoalveolar lavage were negative, as was the Gnexpert for Tuberculosis and culture. However, due to the symptoms and relevant risk factors, it was decided to perform wedge resection by thoracoscopy of the middle lobe, revealing a necrotizing granulomatous process whose histological appearance favored infectious etiology. The patient was diagnosed with miliary tuberculosis because of the symptoms presented, compatible radiology, biopsy findings, and clinical improvement, considering the antituberculosis treatment established. This article describes a case of miliary tuberculosis hematogenous spread in a patient who had previously received intravesical BCG instillations for the treatment of urothelial bladder cancer. Prompt treatment saves lives by avoiding a fatal outcome in these patients.
- Open Access
- 20 January 2025
- Published by Asociacion Colombiana de Neumologia y Cirugia de Torax in Revista Colombiana de Neumología
- Vol. 37 (1) , 63-68
Tuberculosis miliar con diseminación hematógena posterior a instilaciones de BCG intravesical: reporte de un caso
Miliary tuberculosis after intravesical immunotherapy with bacillus Calmette-Guerin (BCG) is rare. A few systemic complications associated with intravesical BCG instillations have been reported in the literature. In this case report, we present a patient with low-grade urothelial bladder cancer who presented clinical manifestations compatible with tuberculosis 4 hours after the last instillation of BCG as immunotherapy treatment for his bladder cancer. Consequently, a systematic approach was performed, finding micronodular infiltrates of random distribution in thoracic images suggestive of a Miliary pattern. The patient started anti-tuberculous treatment at the decision of an interdisciplinary board. Among the tests carried out, it was found that the endoscopic flexible fiberoptic bronchoscopy did not present alterations, the stains for AFB (acid-fast bacilli) in bronchoalveolar lavage were negative, as was the Gnexpert for Tuberculosis and culture. However, due to the symptoms and relevant risk factors, it was decided to perform wedge resection by thoracoscopy of the middle lobe, revealing a necrotizing granulomatous process whose histological appearance favored infectious etiology. The patient was diagnosed with miliary tuberculosis because of the symptoms presented, compatible radiology, biopsy findings, and clinical improvement, considering the antituberculosis treatment established. This article describes a case of miliary tuberculosis hematogenous spread in a patient who had previously received intravesical BCG instillations for the treatment of urothelial bladder cancer. Prompt treatment saves lives by avoiding a fatal outcome in these patients.
- 20 January 2025
- Published by Asociacion Colombiana de Neumologia y Cirugia de Torax in Revista Colombiana de Neumología
- Vol. 37 (1) , 63-68
Open AccessTuberculosis miliar con diseminación hematógena posterior a instilaciones de BCG intravesical: reporte de un caso
Miliary tuberculosis after intravesical immunotherapy with bacillus Calmette-Guerin (BCG) is rare. A few systemic complications associated with intravesical BCG instillations have been reported in the literature. In this case report, we present a patient with low-grade urothelial bladder cancer who presented clinical manifestations compatible with tuberculosis 4 hours after the last instillation of BCG as immunotherapy treatment for his bladder cancer. Consequently, a systematic approach was performed, finding micronodular infiltrates of random distribution in thoracic images suggestive of a Miliary pattern. The patient started anti-tuberculous treatment at the decision of an interdisciplinary board. Among the tests carried out, it was found that the endoscopic flexible fiberoptic bronchoscopy did not present alterations, the stains for AFB (acid-fast bacilli) in bronchoalveolar lavage were negative, as was the Gnexpert for Tuberculosis and culture. However, due to the symptoms and relevant risk factors, it was decided to perform wedge resection by thoracoscopy of the middle lobe, revealing a necrotizing granulomatous process whose histological appearance favored infectious etiology. The patient was diagnosed with miliary tuberculosis because of the symptoms presented, compatible radiology, biopsy findings, and clinical improvement, considering the antituberculosis treatment established. This article describes a case of miliary tuberculosis hematogenous spread in a patient who had previously received intravesical BCG instillations for the treatment of urothelial bladder cancer. Prompt treatment saves lives by avoiding a fatal outcome in these patients.
- Open Access
- 28 August 2023
- Published by Editorial Pontificia Universidad Javeriana in Universitas Médica
- Vol. 64 (3)
Tuberculosis laríngea y pulmonar en un hombre inmunocompetente de 45 años: presentación de un caso
Tuberculosis is a chronic bacterial infection produced by bacterias of the Mycobacterium TB complex. TB usually affects the lungs, but it can also affect other organs such as the larynx. The coexistence of laryngeal and pulmonary TB is uncommon in immunocompetent patients, thus, we present the case of a 45-year-old immunocompetent patient with both entities La tuberculosis es una infección bacteriana crónica inducida por micobacterias del complejo Mycobacterium tuberculosis. La tuberculosis suele afectar a los pulmones, pero también puede afectar a otros órganos como la laringe. La coexistencia de la tuberculosis laríngea y pulmonar es infrecuente en inmunocompetentes, por lo que se presenta el caso de un paciente inmunocompetente de 45 años con ambas entidades.
- 28 August 2023
- Published by Editorial Pontificia Universidad Javeriana in Universitas Médica
- Vol. 64 (3)
Open AccessTuberculosis laríngea y pulmonar en un hombre inmunocompetente de 45 años: presentación de un caso
Tuberculosis is a chronic bacterial infection produced by bacterias of the Mycobacterium TB complex. TB usually affects the lungs, but it can also affect other organs such as the larynx. The coexistence of laryngeal and pulmonary TB is uncommon in immunocompetent patients, thus, we present the case of a 45-year-old immunocompetent patient with both entities La tuberculosis es una infección bacteriana crónica inducida por micobacterias del complejo Mycobacterium tuberculosis. La tuberculosis suele afectar a los pulmones, pero también puede afectar a otros órganos como la laringe. La coexistencia de la tuberculosis laríngea y pulmonar es infrecuente en inmunocompetentes, por lo que se presenta el caso de un paciente inmunocompetente de 45 años con ambas entidades.
- Open Access
- 15 July 2021
- Published by Instituto Nacional de Cancerologia in Revista Colombiana de Cancerología
- Vol. 26 (1) , 14-21
Catéter pleural permanente una opción para el manejo del derrame pleural maligno
Revisión narrativa sobre como el cáncer altera la fisiología de la pleura, como se estudia el derrame pleural maligno y como se puede brindar paliación manejo del paciente con derrame pleural con el catéter pleural permanente o tunelizado cuyo uso demuestra mayores beneficios en diferentes ámbitos clínicos, siendo utilizado principalmente para el tratamiento del derrame pleural tumoral recurrente pero también en algunos casos de derrame pleural benigno recurrente haciéndolo un recurso útil en cáncer avanzado.
- 15 July 2021
- Published by Instituto Nacional de Cancerologia in Revista Colombiana de Cancerología
- Vol. 26 (1) , 14-21
Open AccessCatéter pleural permanente una opción para el manejo del derrame pleural maligno
Revisión narrativa sobre como el cáncer altera la fisiología de la pleura, como se estudia el derrame pleural maligno y como se puede brindar paliación manejo del paciente con derrame pleural con el catéter pleural permanente o tunelizado cuyo uso demuestra mayores beneficios en diferentes ámbitos clínicos, siendo utilizado principalmente para el tratamiento del derrame pleural tumoral recurrente pero también en algunos casos de derrame pleural benigno recurrente haciéndolo un recurso útil en cáncer avanzado.
- Open Access
- 18 January 2021
- Published by Editorial Pontificia Universidad Javeriana in Universitas Médica
- Vol. 62 (1)
Xpert MTB/RIF Ultra innovación en el diagnóstico de la tuberculosis
La tuberculosis es una enfermedad infecciosa con alta mortalidad a nivel global, considerándose un problema de salud pública. La dificultad para su diagnóstico, sobre todo en países de bajos y medianos ingresos limitan su erradicación. El Xpert MTB/RIF es una herramienta molecular que provee un diagnóstico rápido e informa sobre la presencia de cepas resistentes a la rifampicina, permitiendo iniciar un tratamiento de forma rápida y eficaz. Sin embargo, tiene problemas para el diagnóstico de casos paucibacilares y se han reportado falsos positivos respecto a la resistencia a rifampicina y en pacientes con antecedente de tuberculosis. Por esto, aparece el Xpert MTB/RIF Ultra, mostrando mejor sensibilidad para el diagnóstico de la tuberculosis, sobre todo en casos paucibacilares, y disminución de falsos positivos para resistencia a rifampicina; siendo la prueba molecular más recomendada por la OMS. Teniendo en cuenta lo anterior, se espera que mejore el diagnóstico de la enfermedad, dando la oportunidad de iniciar el tratamiento de forma oportuna. En este artículo de revisión se evaluarán retos por mejorar en el diagnóstico de la tuberculosis, características y rendimiento del Xpert MTB/RIF y Xpert MTB/RIF Ultra para formas pulmonares y extrapulmonares y para la detección de la resistencia a la rifampicina.
- 18 January 2021
- Published by Editorial Pontificia Universidad Javeriana in Universitas Médica
- Vol. 62 (1)
Open AccessXpert MTB/RIF Ultra innovación en el diagnóstico de la tuberculosis
La tuberculosis es una enfermedad infecciosa con alta mortalidad a nivel global, considerándose un problema de salud pública. La dificultad para su diagnóstico, sobre todo en países de bajos y medianos ingresos limitan su erradicación. El Xpert MTB/RIF es una herramienta molecular que provee un diagnóstico rápido e informa sobre la presencia de cepas resistentes a la rifampicina, permitiendo iniciar un tratamiento de forma rápida y eficaz. Sin embargo, tiene problemas para el diagnóstico de casos paucibacilares y se han reportado falsos positivos respecto a la resistencia a rifampicina y en pacientes con antecedente de tuberculosis. Por esto, aparece el Xpert MTB/RIF Ultra, mostrando mejor sensibilidad para el diagnóstico de la tuberculosis, sobre todo en casos paucibacilares, y disminución de falsos positivos para resistencia a rifampicina; siendo la prueba molecular más recomendada por la OMS. Teniendo en cuenta lo anterior, se espera que mejore el diagnóstico de la enfermedad, dando la oportunidad de iniciar el tratamiento de forma oportuna. En este artículo de revisión se evaluarán retos por mejorar en el diagnóstico de la tuberculosis, características y rendimiento del Xpert MTB/RIF y Xpert MTB/RIF Ultra para formas pulmonares y extrapulmonares y para la detección de la resistencia a la rifampicina.